106 related articles for article (PubMed ID: 18091746)
1. Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II.
Leclerc PC; Proulx CD; Arguin G; Bélanger S; Gobeil F; Escher E; Leduc R; Guillemette G
Am J Hypertens; 2008 Jan; 21(1):67-71. PubMed ID: 18091746
[TBL] [Abstract][Full Text] [Related]
2. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
Arun KH; Kaul CL; Ramarao P
Cardiovasc Res; 2005 Feb; 65(2):374-86. PubMed ID: 15639476
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells.
Ullian ME; Gelasco AK; Fitzgibbon WR; Beck CN; Morinelli TA
J Am Soc Nephrol; 2005 Aug; 16(8):2346-53. PubMed ID: 15944340
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
6. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
[TBL] [Abstract][Full Text] [Related]
7. Loss-of-function polymorphic variants of the human angiotensin II type 1 receptor.
Hansen JL; Haunsø S; Brann MR; Sheikh SP; Weiner DM
Mol Pharmacol; 2004 Mar; 65(3):770-7. PubMed ID: 14978256
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
[TBL] [Abstract][Full Text] [Related]
9. S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II.
Leclerc PC; Lanctot PM; Auger-Messier M; Escher E; Leduc R; Guillemette G
Br J Pharmacol; 2006 Jun; 148(3):306-13. PubMed ID: 16565729
[TBL] [Abstract][Full Text] [Related]
10. Conformational induction is the key process for activation of the AT1 receptor.
Ellis J; Warburton P; Donnelly D; Balmforth AJ
Biochem Pharmacol; 2006 Feb; 71(4):464-71. PubMed ID: 16343447
[TBL] [Abstract][Full Text] [Related]
11. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
Han YJ; Hu WY; Piano M; de Lanerolle P
Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II inhibitory peptide found in the receptor sequence using peptide array.
Kato R; Kunimatsu M; Fujimoto S; Kobayashi T; Honda H
Biochem Biophys Res Commun; 2004 Feb; 315(1):22-9. PubMed ID: 15013420
[TBL] [Abstract][Full Text] [Related]
13. Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors.
Qi JS; Minor LK; Smith C; Hu B; Yang J; Andrade-Gordon P; Damiano B
Peptides; 2005 Apr; 26(4):683-90. PubMed ID: 15752584
[TBL] [Abstract][Full Text] [Related]
14. Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally.
Guimarães S; Pinheiro H
Cardiovasc Res; 2005 Aug; 67(2):208-15. PubMed ID: 15953595
[TBL] [Abstract][Full Text] [Related]
15. The mechanism behind the inhibitory effect of isoflurane on angiotensin II-induced vascular contraction is different from that of sevoflurane.
Ishikawa A; Ogawa K; Tokinaga Y; Uematsu N; Mizumoto K; Hatano Y
Anesth Analg; 2007 Jul; 105(1):97-102. PubMed ID: 17578963
[TBL] [Abstract][Full Text] [Related]
16. The role of oxidant stress in angiotensin II-mediated contraction of human resistance arteries in the state of health and the presence of cardiovascular disease.
Hussain MB; Püntmann VO; Mayr M; Khong T; Singer DR
Vascul Pharmacol; 2006 Dec; 45(6):395-9. PubMed ID: 16860001
[TBL] [Abstract][Full Text] [Related]
17. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
Weiland F; Verspohl EJ
Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
[TBL] [Abstract][Full Text] [Related]
18. A local pre-receptor mechanism of hormone stimulus amplification: focus on angiotensin II in resistance blood vessels.
Schalekamp MA
J Hypertens; 2006 Sep; 24(9):1787-96. PubMed ID: 16915028
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ responses to thyrotropin-releasing hormone and angiotensin II: the role of plasma membrane integrity and effect of G11alpha protein overexpression on homologous and heterologous desensitization.
Ostasov P; Krusek J; Durchankova D; Svoboda P; Novotny J
Cell Biochem Funct; 2008; 26(2):264-74. PubMed ID: 18041110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
